Msd Pharmaceuticals Private Limited, a active private limited company, was established on 03 December 2004 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230DL2004PTC164459. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹13.20 Cr.
It upholds a compliant status. Employing 1,146 professional, Its leadership includes Rehan Khan Abbas (Managing Director), Chand Berry (Whole-Time Director). Past directors included Leonard Tauro, Naveen Akkinepally Rao, Charles Nigel Thompson. Its latest AGM occurred on 29 August 2025, with the balance sheet filed on 31 March 2025. It is based at 1544, Level 15 Eros Corporate Towers, Nehru Place, New Delhi, Delhi, 110019.
U24230DL2004PTC164459
164459
03 December 2004
₹15.00 Cr
₹13.20 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Msd Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rehan Khan Abbas | Managing Director | 07 May 2021 | Current |
| Chand Berry | Whole-Time Director | 30 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 01 May 2007 | Past |
| Pramod Abcsdd | Director | 01 May 2011 | Past |
| Pramod Abcsdd | Director | 18 Feb 2008 | Past |
| Pramod Abcsdd | Director | 26 Jun 2013 | Past |
| Pramod Abcsdd | Company Secretary | 25 Oct 2012 | Past |
| Pramod Abcsdd | Additional Director | 06 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Msd Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.32% increase. The company also saw a substantial improvement in profitability, with a 24.15% increase in profit. The company's net worth Soared by an impressive increase of 33.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Msd Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Msd Pharmaceuticals has a workforce of 1146 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Msd Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Msd Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Msd Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records. was completed.
Progress on Msd Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Chand Berry was appointed as a Whole-time director was appointed as a Whole-time director on 30 Sep 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
Progress on Satinder Jeet Kaur was appointed as a Company Secretary was appointed as a Company Secretary on 07 Jul 2021 & has been associated with this company since 4 years 4 months . was documented.
Progress on Rehan Khan Abbas was appointed as a Managing Director was appointed as a Managing Director on 07 May 2021 & has been associated with this company since 4 years 6 months . was documented.
The activity Msd Pharmaceuticals Private Limited was registered on 03 Dec 2004 with Roc Delhi & aged 20 years 11 months as per MCA records. was completed.
Cadila Healthcare arm Zydus Healthcare has bought six brands from MSD Pharmaceuticals India, the local arm of US-based Merck & Co..
The CIN of Msd Pharmaceuticals Private Limited is U24230DL2004PTC164459.
Msd Pharmaceuticals Private Limited is headquartered at 1544, Level 15 Eros Corporate Towers, Nehru Place, New Delhi, Delhi, 110019.
Msd Pharmaceuticals Private Limited was incorporated on 03 December 2004.
The current directors of Msd Pharmaceuticals Private Limited are
The primary industry of Msd Pharmaceuticals Private Limited is Trade.
Msd Pharmaceuticals Private Limited is unlisted.
The authorized capital of Msd Pharmaceuticals Private Limited is ₹15.00 Cr, and the paid-up capital is ₹13.20 Cr.
The compliance status of Msd Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX